Biologics developers must consider environmental impact when evaluating single-use technology (SUT) and stainless-steel manufacturing, as both consume significant resources. SUT offers flexibility and efficiency, while stainless steel suits large-volume production. However, both generate waste—stainless steel uses more water and energy, while SUT generates more plastic waste. As sustainability increasingly becomes a priority worldwide, it is now an essential factor in biomanufacturing decisions.
Select contract biomanufacturers are advancing sustainability by incorporating more eco-friendly technologies into drug development. By aligning biologics development with sustainable practices, they not only meet environmental, social, and governance (ESG) commitments but also improve operational efficiency and reduce costs. This whitepaper explores the advantages of sustainability with respect to single-use bioreactors, buffer and media hold containers, centrifuges and other biomanufacturing equipment.